# PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function

> **NCT06153498** · PHASE2 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 36 (estimated)

## Conditions studied

- Mechanically Ventilated Patients

## Interventions

- **DRUG:** Remimazolam besylate

## Key facts

- **NCT ID:** NCT06153498
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-04
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06153498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06153498, "PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06153498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*